| Products/Services Used | Details | Operation |
|---|---|---|
| Peptide Synthesis> | Aseries of biotinylated and non-biotinylated peptides spanning the predicted 3D1 epitope region (residues 748–836 of the SADS-CoV S protein, including the pepAVVNQN peptide with the full sequence A804-V805-V806-N807-Q808-N809) and FITC-HR2 peptide were synthesized commercially by GenScript Biotech (Nanjing, Jiangsu, China). These two peptides were designed and synthesized by GenScript Biotech (Nanjing, Jiangsu, China). | Get A Quote |
The broadly neutralizing monoclonal antibody 3D1 potently neutralizes SADS-CoV by targeting a conserved epitope within the heptad repeat 1 (HR1) domain of the viral spike protein. Structural and biophysical analyses demonstrate that 3D1 binds with high affinity to a specific linear β-turn motif (residues A804-N809) in HR1. High-resolution crystallography reveals that this motif sits within a deep, electrostatically complementary paratope groove. Critically, 3D1 binding competitively inhibits the essential interaction between HR1 and HR2. Notably, its recognition is not dependent on HR1's native helical conformation, as it maintains strong binding to conformationally constrained, stapled helical peptides. Colle... More